Nanobiotix (NBTX) Cost of Revenue: 2020-2024

  • Nanobiotix's Cost of Revenue fell 22.30% to $35,537 in Q2 2024 from the same period last year, while for Jun 2024 it was $157,326, marking a year-over-year decrease of 32.47%. This contributed to the annual value of $70,312 for FY2023, which is 11.05% down from last year.
  • Latest data reveals that Nanobiotix reported Cost of Revenue of $35,537 as of Q2 2024, which was up 0.09% from $35,506 recorded in Q4 2023.
  • Over the past 5 years, Nanobiotix's Cost of Revenue peaked at $96,094 during Q4 2021, and registered a low of $35,506 during Q4 2023.
  • Moreover, its 3-year median value for Cost of Revenue was $38,043 (2022), whereas its average is $39,332.
  • In the last 5 years, Nanobiotix's Cost of Revenue climbed by 12.79% in 2023 and then declined by 22.30% in 2024.
  • Quarterly analysis of 5 years shows Nanobiotix's Cost of Revenue stood at $90,614 in 2020, then climbed by 6.05% to $96,094 in 2021, then decreased by 19.83% to $40,548 in 2022, then rose by 12.79% to $35,506 in 2023, then declined by 22.30% to $35,537 in 2024.
  • Its Cost of Revenue stands at $35,537 for Q2 2024, versus $35,506 for Q4 2023 and $45,735 for Q2 2023.